Novo Nordisk says Hims & Hers' cheaper version of Wegovy pill is illegal

In a move challenging the pharmaceutical industry, Hims & Hers Health is now offering a compounded version of the weight-loss drug Wegovy at a significantly lower price than the medication produced by Novo Nordisk. This action has prompted Novo Nordisk to announce its intention to pursue legal action against the telehealth platform.

A Cheaper Alternative Emerges

Hims & Hers is making its compounded version of Wegovy available for an introductory price of $49 for the first month, as part of a five-month plan. This contrasts sharply with the starting price of $149 for a dose of Novo Nordisk’s Wegovy. Both medications contain semaglutide as the active ingredient.

Did You Know? Hims & Hers states that all active pharmaceutical ingredients used in its compounded treatments are sourced from facilities registered with the Food and Drug Administration.

Hims & Hers asserts that its pill is “formulated to protect the active ingredient during digestion and to support absorption” and utilizes an “innovative delivery method.”

Novo Nordisk Responds

Novo Nordisk has characterized Hims & Hers’ actions as “illegal mass compounding” and has vowed to take legal action. The company has also stated that the Hims & Hers product is “an unapproved, inauthentic, and untested knockoff” of semaglutide.

Expert Insight: The introduction of a lower-cost alternative to a popular weight-loss medication highlights the ongoing tension between pharmaceutical companies and telehealth platforms seeking to expand access to healthcare, and the legal ramifications of compounding medications.

The situation could lead to a protracted legal battle between the two companies. It may also prompt further scrutiny of the compounding pharmacy industry and the regulation of drug manufacturing. Analysts expect other companies may explore similar strategies to offer more affordable versions of popular medications.

Frequently Asked Questions

What is the price difference between Wegovy and the Hims & Hers version?

Novo Nordisk’s Wegovy starts at $149 for a dose, while Hims & Hers is offering its compounded version for an introductory price of $49 for the first month.

What is Novo Nordisk’s response to Hims & Hers’ actions?

Novo Nordisk has stated it will take legal action against Hims & Hers, calling the new product “an unapproved, inauthentic, and untested knockoff.”

What does Hims & Hers say about its product?

Hims & Hers maintains its pill is formulated to protect the active ingredient during digestion and support absorption, and that all ingredients come from FDA-registered facilities.

How might this situation impact access to weight-loss medications for individuals seeking affordable options?

Novo Nordisk says Hims & Hers’ cheaper version of Wegovy pill is illegal